BillionToOne
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BillionToOne and other ETFs, options, and stocks.About BLLN
BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. The company’s patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level.
CEOAtay Oguzhan
CEOAtay Oguzhan
Employees—
Employees—
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2016
Founded2016
Employees—
Employees—
BLLN Key Statistics
Market cap4.42B
Market cap4.42B
Price-Earnings ratio-290.55
Price-Earnings ratio-290.55
Dividend yield—
Dividend yield—
Average volume177.66K
Average volume177.66K
High today$99.97
High today$99.97
Low today$91.83
Low today$91.83
Open price$92.51
Open price$92.51
Volume298.03K
Volume298.03K
52 Week high$138.70
52 Week high$138.70
52 Week low$60.00
52 Week low$60.00
Stock Snapshot
The current BillionToOne(BLLN) stock price is $97.00, with a market capitalization of 4.42B. The stock trades at a price-to-earnings (P/E) ratio of -290.55.
During the trading session on 2025-12-18, BillionToOne(BLLN) shares reached a daily high of $99.97 and a low of $91.83. At a current price of $97.00, the stock is +5.6% higher than the low and still -3.0% under the high.
Trading activity shows a volume of 298.03K, compared to an average daily volume of 177.66K.
The stock's 52-week range extends from a low of $60.00 to a high of $138.70.
The stock's 52-week range extends from a low of $60.00 to a high of $138.70.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own BLLN. This list is generated using Robinhood data, and it’s not a recommendation.